Silence Therapeutics
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $421 | $34 | $159 |
Gross Profit | 304 | 22 | 95 |
EBITDA | -14,826 | -11,657 | -20,801 |
EBIT | -14,931 | -11,770 | -20,957 |
Net Income | -14,931 | -11,770 | -20,958 |
Net Change In Cash | 421 | 34 | 159 |
Free Cash Flow | -15,603 | -17,342 | -10,894 |
Cash | 5,657 | 11,277 | 82,031 |
Basic Shares | 15,744 | 15,744 | 15,744 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $559 | $43,258 | $25,375 | $17,653 |
Gross Profit | 344 | 31,448 | 15,057 | 6,678 |
EBITDA | -88,046 | -48,989 | -49,778 | -39,938 |
EBIT | -88,601 | -49,582 | -50,276 | -40,424 |
Net Income | -88,612 | -45,309 | -43,267 | -41,032 |
Net Change In Cash | 559 | 43,258 | 25,375 | 17,653 |
Free Cash Flow | -62,326 | -54,219 | -39,395 | -57,589 |
Cash | 11,277 | 96,911 | 68,789 | 54,816 |
Basic Shares | 15,743 | 15,416 | 12,364 | 10,731 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.26 |
2026-03-31 | -$0.33 |
2025-12-31 | -$0.27 |
2025-09-30 | -$0.15 |